The impact of the overexpression of human UDP-galactose transporter gene hUGT1 in tobacco plants

Journal of Bioscience and Bioengineering
Mohamed Farouk Mohamed KhalilNobukazu Tanaka

Abstract

When the human UDP-galactose transporter 1 gene (hUGT1) was introduced into tobacco plants, the plants displayed enhanced growth during cultivation, and axillary shoots had an altered determinate growth habit, elongating beyond the primary shoots and having a sympodial growth pattern similar to that observed in tomatoes at a late cultivation stage. The architecture and properties of tissues in hUGT1-transgenic plants were also altered. The leaves had an increase in thickness, due to an increased amount of spongy tissue, and a higher content of chlorophyll a and b; the stems had an increased number of xylem vessels and accumulated lignin and arabinogalactan proteins (AGPs). Some of these characteristics resembled a gibberellin (GA)-responsive phenotype, suggesting involvement of GA. RT-PCR-based analysis of genes involved in GA biosynthesis suggested that the GA biosynthetic pathway was not activated. However, an increase in the proportion of galactose in polysaccharide side chains of AGPs was detected. These results suggested that because of higher UDP-galactose transport from the cytosol to the Golgi apparatus, galactose incorporation into polysaccharide side chains of AGP is involved in the gibberellin response, resulting in ...Continue Reading

References

Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·N Q PalacpacT Seki
Aug 12, 2000·Journal of Experimental Botany·M Mullarkey, P Jones
Sep 28, 2000·The Plant Cell·C J SchultzA Bacic
Oct 24, 2000·Current Opinion in Structural Biology·P M Berninsone, C B Hirschberg
Dec 20, 2000·Trends in Plant Science·P Hedden, A L Phillips
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·H BakkerD Bosch
Apr 20, 2001·Current Opinion in Plant Biology·K Keegstra, N Raikhel
Jan 11, 2002·European Journal of Biochemistry·Hiroaki SegawaNobuhiro Ishida
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert E CampbellRoger Y Tsien
Aug 1, 2002·The Plant Journal : for Cell and Molecular Biology·Yoshihito SuzukiIsomaro Yamaguchi
Aug 29, 2003·The Plant Journal : for Cell and Molecular Biology·S PagnyV Gomord
Aug 28, 2004·Plant Physiology and Biochemistry : PPB·Caroline JolyCatherine Riou-Khamlichi
Oct 14, 2004·Molecular Genetics and Genomics : MGG·M G HandfordP Dupree
May 25, 2005·Plant Biology·C M HuetherE L Decker
Dec 14, 2005·Biochemical and Biophysical Research Communications·Ryo MisakiTatsuji Seki
Dec 20, 2005·Planta·Tatyana Gorshkova, Claudine Morvan
Sep 19, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M HandfordA Orellana
Jan 5, 2007·Annual Review of Plant Biology·Georg J Seifert, Keith Roberts
Feb 9, 2008·Carbohydrate Research·Hans BakkerRita Gerardy-Schahn
May 20, 2008·Current Opinion in Plant Biology·Francisca Reyes, Ariel Orellana

❮ Previous
Next ❯

Citations

Oct 29, 2015·Journal of Bioscience and Bioengineering·Tayebeh AbediNobukazu Tanaka
Apr 23, 2015·Plant Physiology and Biochemistry : PPB·Jeannine SchneiderHerta Steinkellner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.